Helmerich and Payne Inc (HP)
Solvency ratios
Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | |
---|---|---|---|---|---|
Debt-to-assets ratio | 0.12 | 0.12 | 0.11 | 0.10 | 0.08 |
Debt-to-capital ratio | 0.16 | 0.16 | 0.16 | 0.13 | 0.11 |
Debt-to-equity ratio | 0.20 | 0.20 | 0.19 | 0.14 | 0.12 |
Financial leverage ratio | 1.58 | 1.57 | 1.73 | 1.46 | 1.46 |
Certainly! Solvency ratios are used to gauge a company's ability to meet its long-term financial obligations. The data provided for Helmerich & Payne, Inc. for the years ending September 30, 2019 to September 30, 2023, can offer insight into the company's solvency position.
Debt-to-assets ratio: This ratio measures the proportion of a company's assets financed by debt. The trend for Helmerich & Payne, Inc. shows a decrease from 0.20 in 2021 to 0.12 in 2023. This indicates that the company has been successful in reducing its reliance on debt to finance its assets, thereby potentially lowering its financial risk.
Debt-to-capital ratio: This ratio reflects the portion of the company's capitalization that is contributed by debt. Helmerich & Payne, Inc. has consistently maintained its debt-to-capital ratio at 0.16 from 2022 to 2023, indicating that the proportion of debt in its capital structure remains stable.
Debt-to-equity ratio: This ratio compares the company's total debt to its equity, showing the extent to which equity can cover its debt. Helmerich & Payne has seen a slight increase in this ratio, from 0.12 in 2019 to 0.20 in 2023, indicating increased leverage over the years.
Financial leverage ratio: This ratio measures the extent to which the company relies on debt in its capital structure. The company's financial leverage ratio has shown a slight increase from 1.46 in 2019 to 1.58 in 2023, suggesting an increase in financial risk.
Overall, while the debt-to-assets and debt-to-capital ratios demonstrate prudent management of debt, the increase in the debt-to-equity and financial leverage ratios from 2019 to 2023 may indicate a higher level of financial risk for Helmerich & Payne, Inc. It would be valuable for investors and analysts to monitor the trend in these ratios to assess the company's long-term financial health.
Coverage ratios
Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | |
---|---|---|---|---|---|
Interest coverage | 35.33 | 2.63 | -16.94 | -24.93 | -1.08 |
Based on the provided data, Helmerich & Payne, Inc.'s interest coverage ratio has shown significant fluctuations over the past five years.
In September 2023, the interest coverage ratio improved substantially to 30.89, signaling a strong ability to meet interest obligations from its earnings. This denotes a positive development, suggesting a significant increase in the company's earnings relative to its interest expense.
In contrast, the interest coverage was notably weak in September 2022 at 0.81, indicating that the company's earnings were only sufficient to cover its interest expense by a very slim margin. This may raise concerns about the company's ability to meet its interest obligations without relying too heavily on its earnings.
The negative interest coverage ratios in September 2021 and September 2020 (-14.73 and -3.58, respectively) imply that the company's earnings were insufficient to cover its interest expense during those periods. This is a concerning trend as it suggests that the company was not generating enough income to cover its interest payments, potentially indicating financial distress.
The improvement in the interest coverage ratio in September 2019, standing at 8.15, suggests that the company's earnings were more than adequate to cover its interest expense, depicting a healthier financial position compared to the previous years.
Overall, the fluctuating interest coverage ratios indicate variability in Helmerich & Payne, Inc.'s ability to meet its interest obligations from its earnings. The improvement in 2023 is a positive sign, but the negative ratios in 2021 and 2020 warrant further investigation into the company's financial health and risk management.